Literature DB >> 10037684

alphaPix stimulates p21-activated kinase activity through exchange factor-dependent and -independent mechanisms.

R H Daniels1, F T Zenke, G M Bokoch.   

Abstract

Activation of p21-activated kinases (Paks) is achieved through binding of the GTPases Rac or Cdc42 to a conserved domain in the N-terminal regulatory region of Pak. Additional signaling components are also likely to be important in regulating Pak activation. Recently, a family of Pak-interacting guanine nucleotide exchange factors (Pix) have been identified and which are good candidates for regulating Pak activity. Using an active, truncated form of alphaPix (amino acids 155-545), we observe stimulation of Pak1 kinase activity when alphaPix155-545 is co-expressed with Cdc42 and wild-type Pak1 in COS-1 cells. This activation does not occur when we co-express a Pak1 mutant unable to bind alphaPix. The activation of wild-type Pak1 by alphaPix155-545 also requires that alphaPix155-545 retain functional exchange factor activity. However, the Pak1(H83,86L) mutant that does not bind Rac or Cdc42 is activated in the absence of GTPase by alphaPix155-545 and by a mutant of alphaPix155-545 that no longer has exchange factor activity. Pak1 activity stimulated in vitro using GTPgammaS-loaded Cdc42 was also enhanced by recombinant alphaPix155-545 in a binding-dependent manner. These data suggest that Pak activity can be modulated by physical interaction with alphaPix and that this specific effect involves both exchange factor-dependent and -independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037684     DOI: 10.1074/jbc.274.10.6047

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  A PAK1-PIX-PKL complex is activated by the T-cell receptor independent of Nck, Slp-76 and LAT.

Authors:  G M Ku; D Yablonski; E Manser; L Lim; A Weiss
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

Review 2.  Cell migration: GAPs between membrane traffic and the cytoskeleton.

Authors:  I de Curtis
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

Review 3.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

4.  Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated insulin secretion through activation of p21-activated kinase (PAK1) in pancreatic β-Cells.

Authors:  Jia Nie; Chao Sun; Omar Faruque; Guangming Ye; Jia Li; Qiangrong Liang; Zhijie Chang; Wannian Yang; Xiao Han; Yuguang Shi
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

5.  GIT1 activates p21-activated kinase through a mechanism independent of p21 binding.

Authors:  Tsui-Han Loo; Yuen-Wai Ng; Louis Lim; Ed Manser
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

6.  Constitutive p21-activated kinase (PAK) activation in breast cancer cells as a result of mislocalization of PAK to focal adhesions.

Authors:  Mary R Stofega; Luraynne C Sanders; Elisabeth M Gardiner; Gary M Bokoch
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

Review 7.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 8.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

9.  Dictyostelium PAKc is required for proper chemotaxis.

Authors:  Susan Lee; Francisco Rivero; Kyung Chan Park; Emerald Huang; Satoru Funamoto; Richard A Firtel
Journal:  Mol Biol Cell       Date:  2004-10-13       Impact factor: 4.138

10.  Endothelin-1 couples betaPix to p66Shc: role of betaPix in cell proliferation through FOXO3a phosphorylation and p27kip1 down-regulation independently of Akt.

Authors:  Ahmed Chahdi; Andrey Sorokin
Journal:  Mol Biol Cell       Date:  2008-04-02       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.